Azanidazole
Chemical compound
- G01AF13 (WHO) P01AB04 (WHO) QP51AA04 (WHO)
- 4-[(E)-2-(1-methyl-5-nitro-1H-imidazol-
2-yl)ethenyl]pyrimidin-2-amine
- 62973-76-6
Y
- 6436171
- 4940835 Y
- YP2Y0DRX4S
- D03028 Y
- ChEMBL134920 Y
- DTXSID40212180
- Interactive image
- [O-] [N+](=O)c2cnc(\C=C\c1nc(ncc1)N)n2C
InChI
- InChI=1S/C10H10N6O2/c1-15-8(13-6-9(15)16(17)18)3-2-7-4-5-12-10(11)14-7/h2-6H,1H3,(H2,11,12,14)/b3-2+Y
- Key:LHIALLMPKJMSIQ-NSCUHMNNSA-NY
N
Y (what is this?) (verify)Azanidazole is a nitroimidazole derivative used in gynecology for the treatment of trichomonal infections.[1]
References
- ^ Marchionni M, Innocenti Degli A, Penna C (1981). "Combined systemic and topical treatment of trichomoniasis vaginalis with azanidazol". Clin Exp Obstet Gynecol. 8 (1): 18–20. PMID 7307267.
- v
- t
- e
| Tissue amebicides |
| ||||||
|---|---|---|---|---|---|---|---|
| Luminal amebicides |
| ||||||
| Other/ungrouped |
- #WHO-EM
- ‡Withdrawn from market
- Clinical trials:
- †Phase III
- §Never to phase III
 | This antiinfective drug article is a stub. You can help Wikipedia by expanding it. |
- v
- t
- e
 | This drug article relating to the genito-urinary system is a stub. You can help Wikipedia by expanding it. |
- v
- t
- e
